US Stock Futures Rise; All Eyes On Jobs Report

Loading...
Loading...
Pre-open movers
US stock futures gained in early pre-market trade, ahead of nonfarm payrolls data. Data on nonfarm payrolls and consumer spending will be released at 8:30 a.m. ET. The Reuter's/University of Michigan's consumer sentiment index will be released at 9:55 a.m. ET, while data on consumer credit will be released at 3:00 p.m. ET. Futures for the Dow Jones Industrial Average surged 56 points to 15,873.00, while the Standard & Poor's 500 index futures rose 7.10 points to 1,791.10. Futures for the Nasdaq 100 index gained 11.50 points to 3,490.25.
A Peek Into Global Markets
European markets were mostly higher today, with the Spanish Ibex Index dropping 0.52%, London's FTSE 100 index surging 0.45% and STOXX Europe 600 Index rising 0.29%. German DAX 30 index gained 0.51% and French CAC 40 Index rose 0.10%. Asian markets ended mostly higher today. Japan's Nikkei Stock Average jumped 0.81%, China's Shanghai Composite dropped 0.44%, Hong Kong's Hang Seng Index rose 0.13% and India's BSE Sensex jumped 0.18%.
Broker Recommendation
Analysts at Piper Jaffray downgraded Ulta Salon, Cosmetics & Fragrance
ULTA
from “overweight” to “neutral.” The target price for Ulta Salon has been lowered from $129 to $113. Ulta Salon's shares closed at $118.00 yesterday.
Breaking news
  • InterOil IOC has agreed to sell to Total SA TOT a gross 61.3% interest in Petroleum Retention License 15 which contains the Elk-Antelope gas fields in the Gulf Province of Papua New Guinea , and has also granted Total an exclusive right to negotiate a farm-in to all its exploration licenses in Papua New Guinea .To read the full news, click here.
  • Quanta Services PWR today announced that its board of directors has authorized the repurchase of up to $500 million of Quanta's common stock over the next three years. To read the full news, click here.
  • Novartis NVS today announced that results of a Phase III trial of the investigational compound LBH589 (panobinostat) in combination with bortezomib and dexamethasone, met the primary endpoint of significantly extending progression-free survival (PFS) in patients with relapsed or relapsed and refractory multiple myeloma when compared to bortezomib plus dexamethasone alone. To read the full news, click here.
  • Sears Holdings SHLD announced that, in connection with its previously announced consideration of a separation of its Lands' End business, Lands' End, Inc. filed today a registration statement on Form 10 with the Securities and Exchange Commission. To read the full news, click here.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsEurozoneFuturesGlobalPre-Market OutlookMarketsPiper JaffrayUS Stock Futures
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...